Dr. Meredith K. Bartelstein, MD

Dr. Bartelstein practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Bartelstein's NPI, 1487097192, was assigned on April 11, 2013. Dr. Bartelstein graduated from Geisel School Of Medicine At Dartmouth in 2013. Dr. Bartelstein holds New York license 291598.

Dr. Bartelstein's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Bartelstein's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Bartelstein to 1 more home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bartelstein practices, 2 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Bartelstein's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Bartelstein is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Bartelstein's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists arthritis, bursitis, hip replacement, joint or bone infection, joint pain, knee replacement, orthopedic surgery of arms and legs and pelvic and hip fracture among the conditions Dr. Bartelstein treats.

CMS data shows 176 Medicare services from Dr. Bartelstein across 5 procedure codes in 2024, for 151 Medicare patients. Medicare paid $16,823 for them.

CMS counts 151 Medicare patients who saw Dr. Bartelstein in 2024. The largest group is 65 to 74, with 61 patients. 74% of them have high cholesterol, and 73% have high blood pressure. 18% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bartelstein's median patient age at 66, with 59% women.

In 2024, Dr. Bartelstein wrote 11 Medicare Part D claims. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Bartelstein for performance year 2024, reported as part of a group. Dr. Bartelstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bartelstein as offering telehealth.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Bartelstein, published from 2018 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Bone Neoplasms, Giant Cell Tumor of Bone and Arthroplasty, Replacement, Hip. Dr. Bartelstein has published most often in J Bone Oncol. Dr. Bartelstein's most frequent co-authors are John H. Healey, MD, Divya Yerramilli, MD and Erin Faye Gillespie, MD.

CMS Open Payments shows 11 general payments to Dr. Bartelstein from 4 drug and device companies from 2021 to 2025. Travel and lodging make up the largest share, 66% of the total. Globus Medical, Inc. paid the most, $1,156.

Dr. Bartelstein graduated from Geisel School Of Medicine At Dartmouth in 2013.

Dr. Bartelstein is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.